Pharma teams gain early insight into message effectivenessPharmaceutical teams often rely on instinct, retrospective analysis or engagement metrics to judge whether their communications are working. But without a way to measure how messages are actually understood by healthcare professionals, much of that investment remains guesswork. Talking Medicines is addressing this problem with a data-led solution that measures message resonance before launch. Rather than looking at recall or impressions, the company’s platform analyses real-world language used by healthcare professionals to assess whether a message is being received in the way it was intended. At the core of the platform is a proprietary Message Resonance Score™, which rates alignment between a company’s messaging and the language healthcare professionals actually use in conversation.